Ann Dermatol.  2015 Oct;27(5):637-638. 10.5021/ad.2015.27.5.637.

Hypertrichosis and Hyperpigmentation in the Periocular Area Associated with Travoprost Treatment

• Lee HE
• Lim SK
• Im M
• Kim CD
• Seo YJ
• Lee JH
• Lee Y

• KMID: 2171476
• DOI: http://doi.org/10.5021/ad.2015.27.5.637

Abstract

No abstract available.

MeSH Terms

Hyperpigmentation*
Hypertrichosis*
Travoprost

Figure

• 

  Fig. 1 (A) At the time of the first visit, the primary complaints were hyperpigmentation and hypertrichosis in the periocular area. Also note the increased length of the eyelashes. (B) Six months after discontinuation of travoprost. Note the decreased pigmentation in the periocular area. Also, the length and density of both the hairs of the periocular area and the eyelashes are reduced.

Reference

1. Lee AJ, McCluskey P. Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension. Clin Ophthalmol. 2010; 4:741–764.

2. Strober BE, Potash S, Grossman ME. Eyelash hypertrichosis in a patient treated with topical latanoprost. Cutis. 2001; 67:109–110.

3. Kammer JA, Katzman B, Ackerman SL, Hollander DA. Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study. Br J Ophthalmol. 2010; 94:74–79.

4. Johnstone MA, Albert DM. Prostaglandin-induced hair growth. Surv Ophthalmol. 2002; 47:Suppl 1. S185–S202.

5. Ortiz-Perez S, Olver JM. Hypertrichosis of the upper cheek area associated with travoprost treatment of glaucoma. Ophthal Plast Reconstr Surg. 2010; 26:376–377.